CHINA SHINEWAY PHAR.HD-10 revenue breakdown overview

CHINA SHINEWAY PHAR.HD-10 revenue for the last year amounted to 576.36 M EUR, the most of which — 228.90 M EUR — came from its highest performing source at the moment, Injections, the year earlier bringing 197.96 M EUR. The greatest contribution to the revenue figure was made by China including Hong Kong — last year it brought CHINA SHINEWAY PHAR.HD-10 578.91 M EUR, and the year before that — 549.49 M EUR.